Norovirus: Changing epidemiology, changing virology. the challenges for infection control

Journal of Infection Prevention

Volumn 12, Issue 3, 2011, Pages 102-106

  Harris, J P ^a   Allen, D J ^a   Ituriza Gomara, M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955928685     PISSN: 17571774     EISSN: 17571782     Source Type: Journal    
DOI: 10.1177/1757177410392094     Document Type: Article

References (54)

1. Amar CFL, East CL, Gray J., Iturriza-Gomara M., Maclure EA, McLauchlin J. (2007) Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis 26(5): 311-23.
2. Allen DJ, Gray JJ, Gallimore CI, Xerry J., Iturriza Gomara M. (2008) Analysis of amino acid variation in the p2 domain of norovirus vp1 protein reveals putative variant-specific epitopes. PLOS One 3(1): 1-9.
3. Allen DJ, Noad R., Samuel D., Gray JJ, Roy P., Iturriza-Gomara M. (2009) Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virology Journal 6(1): 150.
4. Baron RC, Greenberg HB, Cukor G., Blacklow NR (1984) Serological responses among teenagers after natural exposure to Norwalk virus. J Infect Dis 150(4): 531-4.
5. Belliot G., Sosnovtsev SV, Mitra T., Hammer C., Garfield M., Green KY (2003) In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells. J Virol 77(20): 10957-74.
6. Bu W., Mamedova A., Tan M., Xia M., Jiang X., Hegde RS (2008) Structural basis for the receptor binding specificity of Norwalk virus. J Virol 82(11): 5340-7.
7. Cao S., Lou Z., Tan M., Chen Y., Liu Y., Zhang Z., Zhang XC, Jiang X., Li X., Rao Z. (2007) Structural basis for the recognition of blood group trisaccharides by Norovirus. J Virol 81(11): 5949-57.
8. Clarke IN, Lambden PR (2000) Organization and expression of calicivirus genes. J Infect Dis 181(S2): S309-S316.
9. Dolin R., Blacklow NR, DuPont H., Buscho RF, Wyatt RG, Kasel JA, Hornick R., Chanock R.M. (1972) Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med 140(2): 578-83.
10. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS (2008) Norovirus pathogenesis: Mechanisms of persistence and immune evasion in human populations. Immunol Rev 225(1): 190-211.
11. Duizer E., Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK (2004) Laboratory efforts to cultivate noroviruses. Journal of General Virology 85(Pt1): 79-87.
12. Food Standards Agency (2000) A report of the study of infectious intestinal disease in England. Stationery OfficeL London, pp. 113-26.
13. Gallimore CI, Iturriza-Gomara M., Xerry J., Adigwe J., Gray JJ (2007) Inter-seasonal diversity of Norovirus genotypes: emergence and selection of virus variants. Archives of Virology 152: 1295-303.
14. Glass PJ, White LJ, Ball JM, Leparc-Goffart I., Hardy ME, Estes, M.K. (2000a) Norwalk virus open reading frame 3 encodes a minor structural protein. J Virol 74(14): 6581-91.
15. Glass RI, Noel J., Ando T., Fankhauser R., Belliot G., Mounts A., Parashar UD, Bresee JS, Monroe SS (2000b) The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis 181(Suppl 2): S254-61.
16. Gotz H., Ekdahl K., Lindback J., De Jong B., Hedlund KO, Giesecke J. (2001) Clinical spectrum and transmission characteristics of infection with Norwalk-like virus: fi ndings from a large community outbreak in Sweden. Clin Infect Dis 33(5): 622-8.
17. Hale A., Mattick K., Lewis D., Estes M., Jiang X., Green J., Eglin R., Brown D. (2000) Distinct epidemiological patterns of Norwalk-like virus infection. J Med Virol 62(1): 99-103.
18. Harrington PR, Lindesmith L., Yount B., Moe CL, Baric RS (2002) Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76(23): 12335-43.
19. Harris JP, Edmunds WJ, Pebody R., Brown DW, Lopman BA (2008) Deaths from norovirus among the elderly, England and Wales. Emerg Infect Dis 14(10): 1546-52.
20. Harris JP, Lopman BA, O'Brien SJ (2010) Infection control measures for norovirus: a systematic review of outbreaks in semi-enclosed settings. J Hosp Infect 74(1): 1-9.
21. Huang P., Farkas T., Marionneau S., Zhong W., Ruvoen-Clouet N., Morrow AL, Altaye M., Pickering LK, Newburg DS, LePendu J., Jiang X. (2003) Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 188(1): 19-31.
22. Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow AL, Jiang X. (2005) Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79(11): 6714-22.
23. Hutson AM, Atmar RL, Graham DY, Estes MK (2002) Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185(9): 1335-7.
24. Hutson AM, Atmar RL, Marcus DM, Estes MK (2003) Norwalk virus-like particle hemagglutination by binding to histo-blood group antigens. J Virol 77(1): 405-15.
25. Hutson AM, Atmar RL, Estes MK (2004) Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol 12(6): 279-87. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB (1990) Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 161(1): 18-21.
26. Kapikian AZ, Wyatt RG, Dolin R., Thornhill TS, Kalica AR, Chanock RM (1972) Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 10: 1075-81.
27. Kaplan JE, Schonberger LB, Varano G., Jackman N., Bied J., Gary GW (1982) An outbreak of acute nonbacterial gastroenteritis in a nursing home. Demonstration of person-to-person transmission by temporal clustering of cases. Am J Epidemiol 116(6): 940-8.
28. Karst SM, Wobus CE, Lay M., Davidson J., Virgin HW (2003) STAT1-dependent innate immunity to a Norwalk-like virus. Science 299(5612): 1575-8.
29. Koelle K., Cobey S., Grenfell B., Pascual M. (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314(5807): 1898-903.
30. Koopman JS, Eckert EA, Greenberg HB, Strohm BC, Isaacson RE, Monto AS (1982) Norwalk virus enteric illness acquired by swimming exposure. Am J Epidemiol 115(2): 173-7.
31. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J., Baric RS (2008) Mechanisms of GII.4 Norovirus persistence in human populations. PLoS Med 5(2): e31.
32. Lopman BA, Adak GK, Reacher MH, Brown DW (2003a) Two epidemiologic patterns of norovirus outbreaks: surveillance in England and Wales, 1992-2000. Emerg Infect Dis 9(1): 71-7.
33. Lopman BA, Reacher M., Gallimore C., Adak GK, Gray JJ, Brown DWA. (2003b) Summertime peak of "winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002. BMC Public Health 3: 13.
34. Lopman B., Vennema H., Kohli E., Pothier P., Sanchez A., Negredo A., Buesa J., Schreier E., Reacher M., Brown D., Gray J., Iturriza M., Gallimore C., Bottiger B., Hedlund KO, Torven M., von Bonsdorff CH, Maunula L., Poljsak-Prijatelj M., Zimsek J., Reuter G., Szucs G., Melegh B., Svennson L., van Duijnhoven Y., Koopmans M. (2004a) Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363(9410): 682-8.
35. Lopman BA, Reacher MH, Vipond IB, Hill D., Perry C., Halladay T., Brown DW, Edmunds WJ, Sarangi J. (2004b) Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect Dis 10(10): 1827-34.
36. Lopman BA, Reacher MH, Vipond IB, Sarangi J., Brown DW (2004c) Clinical manifestation of norovirus gastroenteritis in health care settings. Clin infect Dis 39(3) 318-24.
37. Lopman B., Armstrong B., Atchison C., Gray JJ (2009) Host, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and Wales. PloS ONE 4(8): e6671.
38. Mattner F., Sohr D., Heim A., Gastmeier P., Vennema H., Koopmans M. (2006) Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect 12(1): 69-74.
39. Matsui SM, Greenberg HB (2000) Immunity to calicivirus infection. J Infect Dis 181(S2): S331-S335.
40. Mayo MA (2002) A summary of taxonomic changes recently approved by ICTV. Arch Virol 147(8): 1655-63.
41. Mounts AW, Ando T., Koopmans M., Bresee JS, Noel J., Glass RI (2000) Cold weather seasonality of gastroenteritis associated with Norwalklike viruses. J Infect Dis 181(S2): S284-7.
42. Nilsson M., Hedlund KO, Thorhagen M., Larson G., Johansen K., Ekspong A., Svensson L. (2003) Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol 77(24): 13117-24.
43. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR (1977) Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 297(2): 86-9.
44. Phillips G., Tam C., Conti S., Rodrigues LC, Brown D., Iturriza-Gomara M., Gray J., Lopman B. (2010) Community incidence of Norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am J Epid 171(9): 1014-22.
45. Prasad BV, Rothnagel R., Jiang X., Estes MK (1994) Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J Virol 68(8): 5117-25.
46. Siebenga JJ, Vennema H., Renckens B., de Bruin E., van der Veer B., Siezen RJ, Koopmans M. (2007) Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol 81(18): 9932-41.
47. Tan M., Huang P., Meller J., Zhong W., Farkas T., Jiang X. (2003) Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol 77(23): 12562-71.
48. Tan M., Jiang X. (2005) The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol 79(22): 14017-30.
49. Tan M., Meller J., Jiang X. (2006) C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. J Virol 80(15): 7322-31.
50. Tan M., Xia M., Cao S., Huang P., Farkas T., Meller J., Hegde RS, Li X., Rao Z., Jiang X. (2008) Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology 379(2): 324-34.
51. Venkataram Prasad BV, Hardy ME, Dokland T., Bella J., Rossmann MG, Estes MK (1999) X-ray crystallographic structure of the Norwalk virus capsid. Science 286(5438): 287-90.
52. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G., Krug A., Mackenzie JM, Green KY, Virgin HW (2004) Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2(12): e432.
53. Xerry J., Gallimore CI, Iturriza-Gomara M., Allen DJ, Gray JJ (2008) Transmission events within outbreaks of gastroenteritis determined through analysis of nucleotide sequences of the P2 domain of genogroup II noroviruses. J Clin Microbiol 46(3): 947-53.
54. Zheng DP, Ando T., Fankhauser RL, Beard RS, Glass RI, Monroe SS (2006) Norovirus classification and proposed strain nomenclature. Virology 346: 312-23.